Za
Zambon
Milan ITFounded 19062,800 employees
Private CappharmaPrivateRespiratoryCNS
Platform: Respiratory CNS
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Adagratuximab | ZAM-2635 | Phase 2 | 2 | APOC3 | ALL | ||
| Daralemzoparlimab | ZAM-8740 | Phase 1/2 | 1 | JAK2 | Gastric CaPancreatic Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)